These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 481816)

  • 21. Hereditary blood and serum types, PTC test and level of the fifth fraction of serum lactatedehydrogenase in females with gynecological cancer. II. (Communication).
    Milunicová A; Jandová A; Laurová L; Novotná J; Skoda V
    Neoplasma; 1969 Jun; 16(3):311-6. PubMed ID: 4981696
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of serum lactate dehydrogenase (LDH) in oral premalignant and malignant lesions.
    Muralidhar M; Raghavan MR; Bailoor DN; Kamath VV
    Ann Dent; 1988; 47(2):11-5. PubMed ID: 3218938
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental studies of the effect of pan-irradiation on the serum level of lactate dehydrogenase (LDH) and hydroxybutyrate dehydrogenase (HBD) in rabbits. Determination of the serum level of LDH and HBD in patients with malignant neoplasms and their changes in relation to radiotherapy].
    Vacca G; Motta R; Brusori G
    Minerva Med; 1966 Aug; 57(67):2760-4. PubMed ID: 5918090
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malignant hyperthermia - evaluation of serum creatine phosphokinase and lactate dehydrogenase].
    Marukawa S; Shirasaka Y; Ozaki K; Enoue S; Shin S
    Masui; 1975 May; 24(5):489-96. PubMed ID: 1172024
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lactate dehydrogenase activity in the serum of patients with malignant tumors of the mough cavity].
    Casella M
    Arch Stomatol (Napoli); 1968; 9(4):323-9. PubMed ID: 5267530
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum isoenzymes of lactate dehydrogenase in patients with malignant tumors].
    Wüst H
    Verh Dtsch Ges Inn Med; 1965; 71():949. PubMed ID: 5877730
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum lactate dehydrogenase level in various malignancies.
    Malhotra P; Sidhu LS; Singh SP
    Neoplasma; 1986; 33(5):641-7. PubMed ID: 3785469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
    Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
    Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enzyme levels and carcinoma treatment. 1. The serum beta-glucuronidase activity in patients with malignant gynecologic diseases before, during and after the clinical treatment].
    Möbius W; Müller W; Carol W; Bonow A
    Arch Geschwulstforsch; 1967; 30(1):5-41. PubMed ID: 5592891
    [No Abstract]   [Full Text] [Related]  

  • 32. Importance of determinations of serum hexokinase, aldolase, and lactate dehydrogenase activities, and of the lactate/pyruvate-quotient in the diagnosis of malignant tumors.
    Jurga L; Klvana M; Matula P; Wagnerová M
    Neoplasma; 1978; 25(1):95-106. PubMed ID: 634411
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
    Paré P; Talbot J; Hoefs JC
    Gastroenterology; 1983 Aug; 85(2):240-4. PubMed ID: 6862152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative research on the clinical significance of 6-phosphoglucoso-dehydrogenase in the vaginal secretion in normal conditions and in some gynecologic diseases].
    Arezzi Boza E; Remotti G
    Ann Ostet Ginecol Med Perinat; 1966 Dec; 88(12):925-40. PubMed ID: 5998694
    [No Abstract]   [Full Text] [Related]  

  • 35. The lactate dehydrogenases in malignant and non-malignant diseases.
    Oladipo OO; Ajala MO; Afonja OA
    Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum glycosidases in gynecologic cancer patients.
    Chamut S; Japaze H; de Martínez NR
    Medicina (B Aires); 1980; 40(2):151-5. PubMed ID: 7412546
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum lactic dehydrogenase isozyme in malignant diseases for evaluation of treatment.
    Nakamura T
    Bull Tokyo Med Dent Univ; 1972 Mar; 19(1):61-82. PubMed ID: 4504045
    [No Abstract]   [Full Text] [Related]  

  • 38. Dysgerminoma and serum lactic dehydrogenase levels.
    Awais GM
    Obstet Gynecol; 1983 Jan; 61(1):99-101. PubMed ID: 6823354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unusual oxygen-sensitive lactate dehydrogenase isozyme associated with Kirsten murine sarcoma virus in human serum.
    Polonis VR; Anderson GR; Brzykcy J; Vladutiu AO; Manly KF
    Cancer Res; 1984 May; 44(5):2236-9. PubMed ID: 6325000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
    Kher A; Moghe G; Deshpande A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.